HA-155

CAS No. 1229652-22-5

HA-155( Autotaxin Inhibitor IV )

Catalog No. M23406 CAS No. 1229652-22-5

HA155 is a boronic acid-based compound, inhibiting ATX with IC50 of 5.7 nM by selectively binding to its catalytic threonine.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 93 In Stock
10MG 148 In Stock
25MG 310 In Stock
50MG 454 In Stock
100MG 639 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    HA-155
  • Note
    Research use only, not for human use.
  • Brief Description
    HA155 is a boronic acid-based compound, inhibiting ATX with IC50 of 5.7 nM by selectively binding to its catalytic threonine.
  • Description
    HA155 is a boronic acid-based compound, inhibiting ATX with IC50 of 5.7 nM by selectively binding to its catalytic threonine.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Autotaxin Inhibitor IV
  • Pathway
    Angiogenesis
  • Target
    PDE
  • Recptor
    ATX (autotaxin)
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1229652-22-5
  • Formula Weight
    463.29
  • Molecular Formula
    C24H19BFNO5S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:10 mM
  • SMILES
    B(C1=CC=C(C=C1)COC2=CC=C(C=C2)/C=C\3/C(=O)N(C(=O)S3)CC4=CC=C(C=C4)F)(O)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Albers H M H G , Hendrickx L J D , Van Tol R J P , et al. Structure-Based Design of Novel Boronic Acid-Based Inhibitors of Autotaxin[J]. Journal of Medicinal Chemistry, 2011, 54(13):4619-26.
molnova catalog
related products
  • (R)-(-)-Rolipram

    A more active enantiomer of the PDE4 inhibitor rolipram.

  • Bullatine A

    Bullatine A, a diterpenoid alkaloid of the genus Aconitum, possesses anti-rheumatic, anti-inflammatory and anti-nociceptive effects.

  • Zomepirac Sodium

    Zomepirac, formerly marketed as Zomax tablets, was associated with fatal and near-fatal anaphylactoid reactions.